These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 31174390)
1. The In Vitro Effects of Pentamidine Isethionate on Coagulation and Fibrinolysis. Al-Horani RA; Clemons D; Mottamal M Molecules; 2019 Jun; 24(11):. PubMed ID: 31174390 [TBL] [Abstract][Full Text] [Related]
2. Aqueous extract from Brownea grandiceps flowers with effect on coagulation and fibrinolytic system. Pereira B; Brazón J J Ethnopharmacol; 2015 Feb; 160():6-13. PubMed ID: 25460592 [TBL] [Abstract][Full Text] [Related]
3. Revisiting the effect of cholesteryl sulfate on clotting and fibrinolysis: Inhibition of human thrombin and other human blood proteases. Al-Horani RA Heliyon; 2024 Mar; 10(6):e28017. PubMed ID: 38533078 [TBL] [Abstract][Full Text] [Related]
4. Investigation of the anticoagulant activity of cyclic sulfated glycosaminoglycan mimetics. Chiles R; Afosah DK; Al-Horani RA Carbohydr Res; 2023 Jul; 529():108831. PubMed ID: 37209666 [TBL] [Abstract][Full Text] [Related]
5. Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity. Carter RLR; Talbot K; Hur WS; Meixner SC; Van Der Gugten JG; Holmes DT; Côté HCF; Kastrup CJ; Smith TW; Lee AYY; Pryzdial ELG J Thromb Haemost; 2018 Nov; 16(11):2276-2288. PubMed ID: 30176116 [TBL] [Abstract][Full Text] [Related]
6. [Effect of proteolysis inhibitors from Ascaris lumbricoides on the coagulation and fibrinolysis of human plasma]. Kadłubowski R; Ochecka A Angew Parasitol; 1982 May; 23(2):78-82. PubMed ID: 7125286 [TBL] [Abstract][Full Text] [Related]
7. Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation. Kjalke M; Monroe DM; Hoffman M; Oliver JA; Ezban M; Roberts HR Thromb Haemost; 1998 Oct; 80(4):578-84. PubMed ID: 9798973 [TBL] [Abstract][Full Text] [Related]
8. The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood. Hansson KM; Nielsen S; Elg M; Deinum J J Thromb Haemost; 2014 Oct; 12(10):1678-86. PubMed ID: 25142753 [TBL] [Abstract][Full Text] [Related]
9. Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI-deficient plasma in vitro. Minami H; Nogami K; Yada K; Ogiwara K; Furukawa S; Soeda T; Kitazawa T; Shima M J Thromb Haemost; 2019 Jan; 17(1):126-137. PubMed ID: 30444568 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A. Lisman T; Mosnier LO; Lambert T; Mauser-Bunschoten EP; Meijers JC; Nieuwenhuis HK; de Groot PG Blood; 2002 Jan; 99(1):175-9. PubMed ID: 11756168 [TBL] [Abstract][Full Text] [Related]
11. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor. Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988 [TBL] [Abstract][Full Text] [Related]
12. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates. McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185 [TBL] [Abstract][Full Text] [Related]
13. In vitro inhibition of platelet function and coagulation by pentamidine isethionate. Kempin SJ; Jackson CW; Edwards CC Antimicrob Agents Chemother; 1977 Oct; 12(4):451-4. PubMed ID: 921238 [TBL] [Abstract][Full Text] [Related]
14. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood. Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970 [TBL] [Abstract][Full Text] [Related]
15. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor. von dem Borne PA; Cox LM; Bouma BN Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866 [TBL] [Abstract][Full Text] [Related]
16. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro. Torbet J Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404 [TBL] [Abstract][Full Text] [Related]
17. Plasmin-induced procoagulant effects in the blood coagulation: a crucial role of coagulation factors V and VIII. Ogiwara K; Nogami K; Nishiya K; Shima M Blood Coagul Fibrinolysis; 2010 Sep; 21(6):568-76. PubMed ID: 20625277 [TBL] [Abstract][Full Text] [Related]
18. A simple, general approach of allosteric coagulation enzyme inhibition through monosulfated hydrophobic scaffolds. Sidhu PS; Zhou Q; Desai UR Bioorg Med Chem Lett; 2014 Dec; 24(24):5716-5720. PubMed ID: 25453807 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. Levi M; ten Cate H; Bauer KA; van der Poll T; Edgington TS; Büller HR; van Deventer SJ; Hack CE; ten Cate JW; Rosenberg RD J Clin Invest; 1994 Jan; 93(1):114-20. PubMed ID: 8282778 [TBL] [Abstract][Full Text] [Related]
20. Sulfated, low-molecular-weight lignins are potent inhibitorsof plasmin, in addition to thrombin and factor Xa: Novel opportunity for controlling complex pathologies. Henry BL; Abdel Aziz M; Zhou Q; Desai UR Thromb Haemost; 2010 Mar; 103(3):507-15. PubMed ID: 20024500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]